Chronic hepatitis B: a wider range of therapeutic options.

  • Published 2007 in Prescrire international

Abstract

(1) An estimated 15% to 25% of patients with chronic hepatitis B die of complications of the disease, such as cirrhosis and liver cancer. (2) In 2000, interferon monotherapy was the first-line treatment for chronic hepatitis B. This article examines the results of trials of peginterferon and nucleoside/nucleotide analogues (adefovir, entecavir, lamivudine… (More)

Topics

  • Presentations referencing similar topics